Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: Randomised, double-blind, placebo-controlled clinical trial

British Journal of Nutrition

Volumn 111, Issue 7, 2014, Pages 1263-1271

  Mielgo Ayuso, Juan ^a   Barrenechea, Lurdes ^a   Alcorta, Pilar ^b   Larrarte, Eider ^c   Margareto, Javier ^c   Labayen, Idoia ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

^c TECNALIA RESEARCH AND INNOVATION   (Spain)

Author keywords

Cholesterol; Epigallocatechin 3 gallate; Green tea; Insulin resistance; Resting energy expenditure; Weight loss

Indexed keywords

2 OXOISOCAPROIC ACID; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLESTEROL; EPIGALLOCATECHIN GALLATE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA; ANTIOBESITY AGENT; ANTIOXIDANT; CATECHIN; DRUG DERIVATIVE; PLANT EXTRACT;

ADULT; ARTICLE; BODY WEIGHT; CALORIMETRY; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; ENERGY METABOLISM; FAT MASS; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID OXIDATION; LIVER FUNCTION; MAJOR CLINICAL STUDY; OBESITY; RANDOMIZED CONTROLLED TRIAL; TEA; WEIGHT REDUCTION; BODY MASS; CAMELLIA SINENSIS; CHEMISTRY; CONTROLLED CLINICAL TRIAL; DIET THERAPY; LIVER; LOW CALORY DIET; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PLANT LEAF; RISK FACTOR; SPAIN; YOUNG ADULT;

ADULT; ANTI-OBESITY AGENTS; ANTIOXIDANTS; BODY MASS INDEX; CAMELLIA SINENSIS; CATECHIN; DIET, REDUCING; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENERGY METABOLISM; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PLANT EXTRACTS; PLANT LEAVES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84900495551     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513003784     Document Type: Article

References (45)

1. Balentine DA, Wiseman SA & Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37, 693-704.
2. Sae-tan S, Grove KA & Lambert JD (2011) Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res 64, 146-154.
3. Moore RJ, Jackson KG & Minihane AM (2009) Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr 102, 1790-1802.
4. Yang CS, Maliakal P & Meng X (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42, 25-54.
5. Bose M, Lambert JD, Ju J, et al. (2008) The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138, 1677-1683.
6. Hursel R, Viechtbauer W & Westerterp-Plantenga MS (2009) The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond) 33, 956-961.
7. Rains TM, Agarwal S & Maki KC (2011) Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22, 1-7.
8. Hsu CH, Tsai TH, Kao YH, et al. (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27, 363-370.
9. Frank J, George TW, Lodge JK, et al. (2009) Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 139, 58-62.
10. Elfhag K & Rossner S (2005) Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev 6, 67-85.
11. Martin CK, Heilbronn LK, de Jonge L, et al. (2007) Effect of calorie restriction on resting metabolic rate and spontaneous physical activity. Obesity (Silver Spring) 15, 2964-2973.
12. Westerterp-Plantenga MS (2010) Green tea catechins, caffeine and body-weight regulation. Physiol Behav 100, 42-46.
13. Mazzanti G, Menniti-Ippolito F, Moro PA, et al. (2009) Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65, 331-341.
14. Yellapu RK, Mittal V, Grewal P, et al. (2011) Acute liver failure caused by 'fat burners' and dietary supplements: a case report and literature review. Can J Gastroenterol 25, 157-160.
15. Sarma DN, Barrett ML, Chavez ML, et al. (2008) Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 31, 469-484.
16. Temme EH & Van Hoydonck PG (2002) Tea consumption and iron status. Eur J Clin Nutr 56, 379-386.
17. Bantle JP, Wylie-Rosett J, Albright AL, et al. (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31, Suppl. 1, S61-S78.
18. Davis NJ, Emerenini A & Wylie-Rosett J (2006) Obesity management: physician practice patterns and patient preference. Diabetes Educ 32, 557-561.
19. Wylie-Rosett J, Albright AA, Apovian C, et al. (2007) 2006-2007 American Diabetes Association Nutrition Recommendations: issues for practice translation. J Am Diet Assoc 107, 1296-1304.
20. Wallace TM, Levy JC & Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487-1495.
21. Compher C, Frankenfield D, Keim N, et al. (2006) Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J Am Diet Assoc 106, 881-903.
22. Labayen I, Forga L & Martinez JA (1999) Nutrient oxidation and metabolic rate as affected by meals containing different proportions of carbohydrate and fat, in healthy young women. Eur J Nutr 38, 158-166.
23. Labayen I, Diez N, Parra D, et al. (2004) Basal and postprandial substrate oxidation rates in obese women receiving two test meals with different protein content. Clin Nutr 23, 571-578.
24. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest 40, 843-850.
25. 13C]isocaproate breath test. Metabolism 52, 463-467.
26. Ruiz JR, Lasa A, Simon E, et al. (2012) Lower plasma NAMPT/visfatin levels are associated with impaired hepatic mitochondrial function in non-diabetic obese women: a potential link between obesity and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 22, E1-E2.
27. Phung OJ, Baker WL, Matthews LJ, et al. (2010) Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr 91, 73-81.
28. Wang H, Wen Y, Du Y, et al. (2010) Effects of catechin enriched green tea on body composition. Obesity (Silver Spring) 18, 773-779.
29. Yang HY, Yang SC, Chao JC, et al. (2012) Beneficial effects of catechin-rich green tea and inulin on the body composition of overweight adults. Br J Nutr 107, 749-754.
30. Nagao T, Hase T & Tokimitsu I (2007) A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 15, 1473-1483.
31. Suliburska J, Bogdanski P, Szulinska M, et al. (2012) Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res 149, 315-322.
32. Diepvens K, Kovacs EM, Nijs IM, et al. (2005) Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. Br J Nutr 94, 1026-1034.
33. Kovacs EM, Lejeune MP, Nijs I, et al. (2004) Effects of green tea on weight maintenance after body-weight loss. Br J Nutr 91, 431-437.
34. Gregersen NT, Bitz C, Krog-Mikkelsen I, et al. (2009) Effect of moderate intakes of different tea catechins and caffeine on acute measures of energy metabolism under sedentary conditions. Br J Nutr 102, 1187-1194.
35. Rudelle S, Ferruzzi MG, Cristiani I, et al. (2007) Effect of a thermogenic beverage on 24-hour energy metabolism in humans. Obesity (Silver Spring) 15, 349-355.
36. Bérubé-Parent S, Pelletier C, Doré J, et al. (2005) Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br J Nutr 94, 432-436.
37. Thielecke F, Rahn G, Bohnke J, et al. (2010) Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study. Eur J Clin Nutr 64, 704-713.
38. Dulloo AG, Duret C, Rohrer D, et al. (1999) Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70, 1040-1045.
39. Brown AL, Lane J, Coverly J, et al. (2009) Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 101, 886-894.
40. Fukino Y, Ikeda A, Maruyama K, et al. (2008) Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 62, 953-960.
41. Chan CC, Koo MW, Ng EH, et al. (2006) Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome - a randomized placebo-controlled trial. J Soc Gynecol Investig 13, 63-68.
42. Ryu OH, Lee J, Lee KW, et al. (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71, 356-358.
43. Hsu CH, Liao YL, Lin SC, et al. (2011) Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebocontrolled clinical trial. Altern Med Rev 16, 157-163.
44. Hursel R & Westerterp-Plantenga MS (2010) Thermogenic ingredients and body weight regulation. Int J Obes (Lond) 34, 659-669.
45. Ruiz JR, Ortega FB, Rodriguez G, et al. (2011) Validity of resting energy expenditure predictive equations before and after an energy-restricted diet intervention in obese women. PLoS ONE 6, e23759.